What are advantages and limits of MAbs in immunotherapy of infectious diseases?

Promising against: — Multi-resistant bacteria — Emerging diseases — Viruses Limits — High cost — Narrow specificity — Limited market — In some cases: — Availability of anti-microbial drugs — Availability of vaccines